doi:10.3969/j.issn.1004-583X.2024.10.012

Abstract

CLC Number:

R575.3

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2024.10.012

https://huicui.hebmu.edu.cn/EN/Y2024/V39/I10/935

References 32

[1]	Shingina A, Mukhtar N, Wakim-Fleming J, et al. Acute liver failure guidelines[J]. Am J Gastroenterol, 2023, 118(7): 1128-1153. doi: 10.14309/ajg.0000000000002340 pmid: 37377263
[2]	Larsen FS. Artificial liver support in acute and acute-on-chronic liver failure[J]. Curr Opin Crit Care, 2019, 25(2): 187-191. doi: 10.1097/MCC.0000000000000584 pmid: 30672818
[3]	Khamri W, Abeles RD, Hou TZ, et al. Increased expression of cytotoxic T-lymphocyte-Associated protein 4 by T cells, induced by B7 in sera, reduces adaptive immunity in patients with acute liver failure[J]. Gastroenterology, 2017, 153(1): 263-276.e8. doi: S0016-5085(17)30332-3 pmid: 28363639
[4]	白浪, 陈煜, 陈源文, 等. 人工肝血液净化技术临床应用专家共识(2022年版)[J]. 临床肝胆病杂志, 2022, 38(4):767-775.
[5]	Wendon J, Cordoba J, Dhawan A, et al. EASL clinical practical guidelines on the management of acute (fulminant) liver failure[J]. J Hepatol, 2017, 66(5): 1047-1081. doi: S0168-8278(16)30708-5 pmid: 28417882
[6]	Akdogan M, Camci C, Gurakar A, et al. The effect of total plasma exchange on fulminant hepatic failure[J]. J Clin Apher, 2006, 21(2):96-99. pmid: 16142721
[7]	Larsen FS, Schmidt LE, Bernsmeier C, et al. High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial[J]. J Hepatol, 2016, 64(1): 69-78. doi: 10.1016/j.jhep.2015.08.018 pmid: 26325537
[8]	Chen KJ, Chen TH, Sue YM, et al. High-volume plasma exchange in a patient with acute liver failure due to non-exertional heat stroke in a sauna[J]. J Clin Apher, 2014, 29(5): 281-283.
[9]	Nakae H, Yonekawa C, Wada H, et al. Effectiveness of combining plasma exchange and continuous hemodiafiltration (combined modality therapy in a parallel circuit) in the treatment of patients with acute hepatic failure[J]. Ther Apher, 2002, 5(6): 471-475.
[10]	Morgan SM, Zantek ND. Therapeutic plasma exchange for fulminant hepatic failure secondary to Wilson's disease[J]. J Clin Apher, 2012, 27(5): 282-286. doi: 10.1002/jca.21239 pmid: 22718095
[11]	Cheng YL, Chang CH, Chen WT, et al. Prognostic factors and treatment effect of standard-volume plasma exchange for acute and acute-on-chronic liver failure: A single-center retrospective study[J]. Transfus Apher Sci, 2018, 57(4): 537-543.
[12]	Liu CT, Chen TH, Cheng CY. Successful treatment of drug-induced acute liver failure with high-volume plasma exchange[J]. J Clin Apher, 2013, 28(6): 430-434.
[13]	Maiwall R, Bajpai M, Singh A, et al. Standard-volume plasma exchange improves outcomes in patients with acute liver failure: A randomized controlled trial[J]. Clin Gastroenterol Hepatol, 2022, 20(4): e831-e854.
[14]	Yao J, Li S, Zhou L, et al. Therapeutic effect of double plasma molecular adsorption system and sequential half-dose plasma exchange in patients with HBV-related acute-on-chronic liver failure[J]. J Clin Apher, 2019, 34(4): 392-398. doi: 10.1002/jca.21690 pmid: 30758886
[15]	Sen S, Ytrebø LM, Rose C, et al. Albumin dialysis: A new therapeutic strategy for intoxication from protein-bound drugs[J]. Intensive Care Med, 2004, 30(3): 496-501.
[16]	Saliba F, Camus C, Durand F, et al. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: A randomized, controlled trial[J]. Ann Intern Med, 2013, 159(8):522-531. doi: 10.7326/0003-4819-159-8-201310150-00005 pmid: 24126646
[17]	Cardoso FS, Gottfried M, Tujios S, et al. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure[J]. Hepatology, 2018, 67(2): 711-720. doi: 10.1002/hep.29488 pmid: 28859230
[18]	Schmidt LE, Wang LP, Hansen BA. Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trial[J]. Liver Transpl, 2003, 9(3): 290-297.
[19]	Schmidt LE, Tofteng F, Strauss GI, et al. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy[J]. Scand J Gastroenterol, 2004, 39(10): 974-980.
[20]	Saliba F, Bañares R, Larsen FS, et al. Artificial liver support in patients with liver failure: A modified DELPHI consensus of international experts[J]. Intensive Care Med, 2022, 48(10):1352-1367. doi: 10.1007/s00134-022-06802-1 pmid: 36066598
[21]	Mitzner SR, Klammt S, Peszynski P, et al. Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system[J]. Ther Apher, 2001, 5(5): 417-422. doi: 10.1046/j.1526-0968.2001.00388.x pmid: 11778928
[22]	Stange J, Mitzner SR, Risler T, et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support[J]. Artif Organs, 1999, 23(4):319-330. doi: 10.1046/j.1525-1594.1999.06122.x pmid: 10226696
[23]	Camus C, Locher C, Saliba F, et al. Outcome of patients treated with molecular adsorbent recirculating system albumin dialysis: A national multicenter study[J]. JGH Open, 2020, 4(4): 757-763. doi: 10.1002/jgh3.12359 pmid: 32782967
[24]	Kanjo A, Ocskay K, Gede N, et al. Efficacy and safety of liver support devices in acute and hyperacute liver failure: A systematic review and network meta-analysis[J]. Sci Rep, 2021, 11(1): 4189. doi: 10.1038/s41598-021-83292-z pmid: 33602961
[25]	Fujiwara K, Abe R, Yasui S, et al. High recovery rate of consciousness by high-volume filtrate hemodiafiltration for fulminant hepatitis[J]. Hepatol Res, 2018, 49(2): 224-231.
[26]	Fujiwara K, Oda S, Abe R, et al. On-line hemodiafiltration or high-flow continuous hemodiafiltration is one of the most effective artificial liver support devices for acute liver failure in Japan[J]. J Hepatobiliary Pancreat Sci, 2015, 22(3): 246-247. doi: 10.1002/jhbp.204 pmid: 25565563
[27]	Takikawa Y, Kakisaka K, Suzuki Y, et al. Multicenter study on the consciousness-regaining effect of a newly developed artificial liver support system in acute liver failure: An on-line continuous hemodiafiltration system[J]. Hepatol Res, 2020, 51(2):216-226.
[28]	Nakae H, Eguchi Y, Saotome T, et al. Multicenter study of plasma diafiltration in patients with acute liver failure[J]. Ther Apher Dial, 2010, 14(5):444-450.
[29]	Pless G, Sauer IM. Bioartificial liver: current status[J]. Transplant Proc, 2005, 37(9): 3893-3895.
[30]	朱雪晶, 黄伟健, 鄢和新. 生物型人工肝支持系统种子细胞的来源与应用[J]. 临床肝胆病杂志, 2024, 40(2):246-251.
[31]	Shi XL, Gao Y, Yan Y, et al. Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes[J]. Cell Res, 2016, 26(2): 206-216.
[32]	Wang Y, Zheng Q, Sun Z, et al. Reversal of liver failure using a bioartificial liver device implanted with clinical-grade human-induced hepatocytes[J]. Cell Stem Cell, 2023, 30(5): 617-631.e8. doi: 10.1016/j.stem.2023.03.013 pmid: 37059100

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 32

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Chen Li;Huang Xiaoping;Huang Yan;Sun Wei;Zhu Haichao;Gan Jianhe. Th17,Treg and Th17/Treg in peripheral blood of patients with hepatitis B virus-related subacute-on-chronic liver failure and their relevance with model for end-stage liver disease score [J]. Clinical Focus, 2015, 30(12): 1382-1385.
[2]	. [J]. CLINICAL FOCUS, 2013, 28(12): 1415-1417.
[3]	. [J]. CLINICAL FOCUS, 2013, 28(3): 328-328.
[4]	WEI Zheng;XU Tian-min. Effect of glucocorticoid in treatment of patients with early liver failure [J]. Clinical Focus, 2012, 27(10): 840-843.
[5]	. [J]. Clinical Focus, 2011, 26(15): 13701380-0.
[6]	. [J]. CLINICAL FOCUS, 2010, 25(22): 2005-2006.
[7]	. [J]. CLINICAL FOCUS, 2009, 24(24): 2149-2150.
[8]	. [J]. CLINICAL FOCUS, 2009, 24(16): 1446-1448.
[9]	. [J]. CLINICAL FOCUS, 2009, 24(16): 1462-1462.
[10]	. [J]. CLINICAL FOCUS, 2009, 24(14): 1253-1254.
[11]	WANG Xin;WANG Bang-mao;LIU Wen-tian;CAO Xiao-cang;ZHENG Zhong-qing. Clinical value of MELD and APACHE Ⅱ score to predict prognosis of acute-on-chronic liver failure [J]. CLINICAL FOCUS, 2009, 24(7): 581-583.
[12]	. [J]. CLINICAL FOCUS, 2009, 24(6): 515-516.
[13]	. [J]. CLINICAL FOCUS, 2009, 24(4): 347-347.
[14]	. [J]. CLINICAL FOCUS, 2008, 23(12): 910-912.
[15]	. [J]. CLINICAL FOCUS, 2007, 22(18): 1337-1338.